1887

Abstract

attenuated strain RB51 vaccine (RB51) is widely used in prevention of bovine brucellosis. Although vaccination with this strain has been shown to be effective in conferring protection against bovine brucellosis, RB51 has several drawbacks, including residual virulence for animals and humans. Therefore, a safe and efficacious vaccine is needed to overcome these disadvantages. In this study, we constructed several gene deletion mutants (Δ, Δ and Δ single mutants, and ΔΔ and ΔΔ double mutants) of RB51 with the aim of increasing the safety of the possible use of these mutants as vaccine candidates. The RB51Δ, RB51Δ, RB51Δ, RB51ΔΔ and RB51ΔΔ mutants exhibited significant attenuation of virulence when assayed in murine macrophages or in BALB/c mice. A single intraperitoneal immunization with RB51Δ, RB51Δ, RB51ΔΔ or RB51ΔΔ mutants was rapidly cleared from mice within 3 weeks, whereas the RB51Δ mutant and RB51 were detectable in spleens until 4 and 7 weeks, respectively. Vaccination with a single dose of RB51 mutants induced lower protective immunity in mice than did parental RB51. However, a booster dose of these mutants provided significant levels of protection in mice against challenge with either the virulent homologous strain 2308 or the heterologous strain 26. In addition, these mutants were found to induce a mixed but T-helper-1-biased humoral and cellular immune response in immunized mice. These data suggest that immunization with a booster dose of attenuated RB51 mutants provides an attractive strategy to protect against either bovine or canine brucellosis.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000170
2015-11-01
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/micro/161/11/2137.html?itemId=/content/journal/micro/10.1099/mic.0.000170&mimeType=html&fmt=ahah

References

  1. Alcantara R.B., Read R.D., Valderas M.W., Brown T.D., Roop R.M. II. ( 2004;). Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model. Infect Immun 72: 4911–4917 [CrossRef] [PubMed].
    [Google Scholar]
  2. Arellano-Reynoso B., Díaz-Aparicio E., Leal-Hernández M., Hernández L., Gorvel J.P.. ( 2004;). Intracellular trafficking study of a RB51 B. abortus vaccinal strain isolated from cow milk. Vet Microbiol 98: 307–312 [CrossRef] [PubMed].
    [Google Scholar]
  3. Arenas-Gamboa A.M., Ficht T.A., Kahl-McDonagh M.M., Rice-Ficht A.C.. ( 2008;). Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge. Infect Immun 76: 2448–2455 [CrossRef] [PubMed].
    [Google Scholar]
  4. Ashford D.A., di Pietra J., Lingappa J., Woods C., Noll H., Neville B., Weyant R., Bragg S.L., Spiegel R.A., other authors. ( 2004;). Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 22: 3435–3439 [CrossRef] [PubMed].
    [Google Scholar]
  5. Avila-Calderón E.D., Lopez-Merino A., Sriranganathan N., Boyle S.M., Contreras-Rodríguez A.. ( 2013;). A history of the development of Brucella vaccines. BioMed Res Int 2013: 743509 [CrossRef] [PubMed].
    [Google Scholar]
  6. Bae D.H., Lee Y.J.. ( 2009;). Occurrence of canine brucellosis in Korea and polymorphism of Brucella canis isolates by infrequent restriction site-PCR. Korean J Vet Res 49: 105–111.
    [Google Scholar]
  7. Baek B.K., Lim C.W., Rahman M.S., Kim C.H., Oluoch A., Kakoma I.. ( 2003;). Brucella abortus infection in indigenous Korean dogs. Can J Vet Res 67: 312–314 [PubMed].
    [Google Scholar]
  8. Baek B.K., Park M.Y., Islam M.A., Khatun M.M., Lee S.I., Boyle S.M.. ( 2012;). The first detection of Brucella canis in cattle in the Republic of Korea. Zoonoses Public Health 59: 77–82 [CrossRef] [PubMed].
    [Google Scholar]
  9. Baldwin C.L., Parent M.. ( 2002;). Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet Microbiol 90: 367–382 [CrossRef] [PubMed].
    [Google Scholar]
  10. Caporale V., Bonfini B., Di Giannatale E., Di Provvido A., Forcella S., Giovannini A., Tittarelli M., Scacchia M.. ( 2010;). Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo. Vet Ital 46: (13-19), 5–11 [PubMed].
    [Google Scholar]
  11. Corbel M.J.. ( 2006;). Brucellosis in Humans and Animals Geneva: World Health Organization;.
    [Google Scholar]
  12. Forbes L.B.. ( 1990;). Brucella abortus infection in 14 farm dogs. J Am Vet Med Assoc 196: 911–916 [PubMed].
    [Google Scholar]
  13. Godfroid J., Cloeckaert A., Liautard J.P., Kohler S., Fretin D., Walravens K., Garin-Bastuji B., Letesson J.J.. ( 2005;). From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 36: 313–326 [CrossRef] [PubMed].
    [Google Scholar]
  14. Goldman B.S., Gabbert K.K., Kranz R.G.. ( 1996;). The temperature-sensitive growth and survival phenotypes of Escherichia coli cydDC and cydAB strains are due to deficiencies in cytochrome bd and are corrected by exogenous catalase and reducing agents. J Bacteriol 178: 6348–6351 [PubMed].
    [Google Scholar]
  15. Her M., Cho D.H., Kang S.I., Lim J.S., Kim H.J., Cho Y.S., Hwang I.Y., Lee T., Jung S.C., Yoo H.S.. ( 2010;). Outbreak of brucellosis in domestic elk in Korea. Zoonoses Public Health 57: 155–161 [CrossRef] [PubMed].
    [Google Scholar]
  16. Hur J., Baek B.K.. ( 2010;). Efficacy of Brucella abortus strain RB51 vaccine in Korean mongrel dogs against virulent strains of B. abortus biotype 1 and B. canis. Korean J Vet Serv 33: 29–35.
    [Google Scholar]
  17. Jang Y., Kim H., Bang H.A., Lee M.J., Che N.H., Lee W.C.. ( 2011;). Epidemiological aspects of human brucellosis and leptospirosis outbreaks in Korea. J Clin Med Res 3: 199–202 [PubMed].
    [Google Scholar]
  18. Jiménez de Bagüés M.P., Elzer P.H., Jones S.M., Blasco J.M., Enright F.M., Schurig G.G., Winter A.J.. ( 1994;). Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun 62: 4990–4996 [PubMed].
    [Google Scholar]
  19. Kahl-McDonagh M.M., Ficht T.A.. ( 2006;). Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice. Infect Immun 74: 4048–4057 [CrossRef] [PubMed].
    [Google Scholar]
  20. Kang S.I., Heo E.J., Cho D., Kim J.W., Kim J.Y., Jung S.C., Her M.. ( 2011;). Genetic comparison of Brucella canis isolates by the MLVA assay in South Korea. J Vet Med Sci 73: 779–786 [CrossRef] [PubMed].
    [Google Scholar]
  21. Leal-Hernandez M., Díaz-Aparicio E., Pérez R., Andrade L.H., Arellano-Reynoso B., Alfonseca E., Suárez-Güemes F.. ( 2005;). Protection of Brucella abortus RB51 revaccinated cows, introduced in a herd with active brucellosis, with presence of atypical humoral response. Comp Immunol Microbiol Infect Dis 28: 63–70 [CrossRef] [PubMed].
    [Google Scholar]
  22. Lee J.J., Simborio H.L., Reyes A.W.B., Kim D.G., Hop H.T., Min W., Her M., Jung S.C., Yoo H.S., Kim S.. ( 2015;). Immunoproteomic identification of immunodominant antigens independent of the time of infection in Brucella abortus 2308-challenged cattle. Vet Res 46: 17 [CrossRef] [PubMed].
    [Google Scholar]
  23. Lucero N.E., Corazza R., Almuzara M.N., Reynes E., Escobar G.I., Boeri E., Ayala S.M.. ( 2010;). Human Brucella canis outbreak linked to infection in dogs. Epidemiol Infect 138: 280–285 [CrossRef] [PubMed].
    [Google Scholar]
  24. McQuiston J.R., Schurig G.G., Sriranganathan N., Boyle S.M.. ( 1995;). Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol Biol 47: 143–148 [PubMed].
    [Google Scholar]
  25. Moriyón I., Grilló M.J., Monreal D., González D., Marín C., López-Goñi I., Mainar-Jaime R.C., Moreno E., Blasco J.M.. ( 2004;). Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35: 1–38 [CrossRef] [PubMed].
    [Google Scholar]
  26. Olsen S.C., Johnson C.S.. ( 2012;). Efficacy of dart or booster vaccination with strain RB51 in protecting bison against experimental Brucella abortus challenge. Clin Vaccine Immunol 19: 886–890 [CrossRef] [PubMed].
    [Google Scholar]
  27. Palmer M.V., Cheville N.F.. ( 1997;). Effects of oral or intravenous inoculation with Brucella abortus strain RB51 vaccine in beagles. Am J Vet Res 58: 851–856 [PubMed].
    [Google Scholar]
  28. Park M.Y., Lee C.S., Choi Y.S., Park S.J., Lee J.S., Lee H.B.. ( 2005;). A sporadic outbreak of human brucellosis in Korea. J Korean Med Sci 20: 941–946 [CrossRef] [PubMed].
    [Google Scholar]
  29. Pasquali P., Adone R., Gasbarre L.C., Pistoia C., Ciuchini F.. ( 2001;). Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infect Immun 69: 6541–6544 [CrossRef] [PubMed].
    [Google Scholar]
  30. Poole R.K., Gibson F., Wu G.. ( 1994;). The cydD gene product, component of a heterodimeric ABC transporter, is required for assembly of periplasmic cytochrome c and of cytochrome bd in Escherichia coli. FEMS Microbiol Lett 117: 217–223 [CrossRef] [PubMed].
    [Google Scholar]
  31. Schurig G.G., Sriranganathan N., Corbel M.J.. ( 2002;). Brucellosis vaccines: past, present and future. Vet Microbiol 90: 479–496 [CrossRef] [PubMed].
    [Google Scholar]
  32. Seleem M.N., Boyle S.M., Sriranganathan N.. ( 2010;). Brucellosis: a re-emerging zoonosis. Vet Microbiol 140: 392–398 [CrossRef] [PubMed].
    [Google Scholar]
  33. Stevens M.G., Olsen S.C., Pugh G.W., Jr, Brees D.. ( 1995;). Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect Immun 63: 264–270 [PubMed].
    [Google Scholar]
  34. Trant C.G., Lacerda T.L., Carvalho N.B., Azevedo V., Rosinha G.M., Salcedo S.P., Gorvel J.P., Oliveira S.C.. ( 2010;). The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice. Infect Immun 78: 2283–2291 [CrossRef] [PubMed].
    [Google Scholar]
  35. Truong L.Q., Kim J.T., Yoon B.I., Her M., Jung S.C., Hahn T.W.. ( 2011;). Epidemiological survey for Brucella in wildlife and stray dogs, a cat and rodents captured on farms. J Vet Med Sci 73: 1597–1601 [CrossRef] [PubMed].
    [Google Scholar]
  36. Truong Q.L., Cho Y., Barate A.K., Kim S., Hahn T.W.. ( 2014;). Characterization and protective property of Brucella abortus cydC and looP mutants. Clin Vaccine Immunol 21: 1573–1580 [CrossRef] [PubMed].
    [Google Scholar]
  37. Truong Q.L., Cho Y., Barate A.K., Kim S., Watarai M., Hahn T.W.. ( 2015;). Mutation of purD and purF genes further attenuates Brucella abortus strain RB51. Microb Pathog 79: 1–7 [CrossRef] [PubMed].
    [Google Scholar]
  38. Wang Z., Wu Q.. ( 2013;). Research progress in live attenuated Brucella vaccine development. Curr Pharm Biotechnol 14: 887–896 [CrossRef] [PubMed].
    [Google Scholar]
  39. Wang Z., Niu J., Wang S., Lv Y., Wu Q.. ( 2013;). In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp. Clin Vaccine Immunol 20: 174–180 [CrossRef] [PubMed].
    [Google Scholar]
  40. Wanke M.M.. ( 2004;). Canine brucellosis. Anim Reprod Sci 82–83: 195–207 [CrossRef] [PubMed].
    [Google Scholar]
  41. Yang X., Thornburg T., Walters N., Pascual D.W.. ( 2010;). (znuA(purE Brucella abortus 2308 mutant as a live vaccine candidate. Vaccine 28: 1069–1074 [CrossRef] [PubMed].
    [Google Scholar]
  42. Yoon H., Moon O.K., Her M., Carpenter T.E., Kim Y.J., Jung S., Lee S.J.. ( 2010;). Impact of bovine brucellosis eradication programs in the Republic of Korea. Prev Vet Med 95: 288–291 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000170
Loading
/content/journal/micro/10.1099/mic.0.000170
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error